MRA Associates USA’s Humana HUM Stock Holding History

MRA Associates USA’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-89	Closed	-$23.6K	–	134
2019 Q2	$23.6K	Buy	+89	New	+$22.6K	0.09%	89

Other funds holding HUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MRA Associates USA's HUM Position: Q3 2019 in Review

MRA Associates USA sold out of Humana (HUM) in Q3 2019, closing a stake of 89 shares — an estimated $23.6K sold.

MRA Associates USA first reported a position in HUM in Q2 2019 and held it in 1 quarter. The position peaked at $23.6K in Q2 2019. 734 funds tracked by Wall St. Rank hold HUM as of Q3 2019.

MRA Associates USA reported no remaining Humana position as of Q3 2019 after selling out during the quarter.
MRA Associates USA sold 89 Humana shares in Q3 2019, an estimated $23.6K.
MRA Associates USA first reported a position in Humana in Q2 2019 and held it in 1 quarter.
MRA Associates USA's Humana position peaked at $23.6K in Q2 2019.
734 funds tracked by Wall St. Rank held Humana as of Q3 2019.

Based on MRA Associates USA's 13F filing for Q3 2019, filed 8 Nov 2019.